feedback

Course Director

Matt T. Rosenberg, MD
Matt T. Rosenberg, MD

Medical Director
Mid-Michigan Health Centers
Jackson, Michigan

Faculty

Theodore W. Johnson, II
Theodore W. Johnson, II, MD, MPH

Paul W. Seavey Chair in Medicine
Emory University School of Medicine
Atlanta Site Director, Birmingham/Atlanta VA GRECC
Chief, Emory Division of General Medicine and Geriatrics
Chair, Emory Department of Family and Preventive Medicine
Atlanta, Georgia

Scott A. MacDiarmid
Scott A. MacDiarmid, MD

Director
Alliance Urology Specialists Bladder Control and Pelvic Pain Center
Clinical Professor
Dept of Urology
University of North Carolina
Chapel Hill, North Carolina

Accredited by

Medical Learning Institute, Inc.

Activity Details

Credit Types:CME
Credit Amount:1.75 Credits
Release Date:2016-Jun-17
Expiration Date:2017-Jun-16
Estimated Time for Completion:105 minutes
Registration Required:No
Cost:Free of Charge

Activity Description and Educational Objectives


Internists, primary care physicians, and other healthcare professionals in the primary-care setting play a central role in the initial assessment, diagnosis, and management of patients with overactive bladder (OAB). This activity, which is based on a recent live symposium, is designed to provide primary-care practitioners with an enhanced understanding of OAB symptoms, treatment goals, and expected outcomes of OAB therapy; benefits and limitations of behavioral and pharmacologic interventions; and the differences in the mechanisms of action and clinical profiles of the different agent classes, such as antimuscarinics and the β3 adrenergic agonists.
The faculty panel discusses patient case scenarios featuring both younger and elderly patients, with and without comorbidities, in first-line or refractory disease settings, and provides their expert insights on selecting therapy and optimally sequencing the available therapies through multiple lines of treatment in the individual patient. Our panel also highlights their expert recommendations on effective communication techniques and patient counseling tactics to enhance adherence to OAB therapy, minimize treatment-related adverse effects, and improve treatment satisfaction.

Upon completion of this activity, participants should be better able to:
  • Employ effective patient engagement strategies and diagnostic tools for screening and assessing overactive bladder (OAB)
  • Discuss the benefits and risks of currently recommended therapeutic approaches for the management of OAB, including behavioral interventions and pharmacologic options
  • Tailor treatment for individual patients with OAB with an understanding of the differences among available therapies, impact of patient comorbidities and disease-related features, and treatment-emergent adverse events
  • Optimize sequencing of available strategies in patients who fail or progress after initial therapy

Target Audience

This activity has been designed to meet the educational needs of internists, primary care physicians, and other healthcare professionals who treat patients with OAB in the primary care setting.

Requirements for Successful Completion

In order to receive credit, participants must view the activity and complete the post-test and evaluation form. A score of 70% or higher is needed to obtain CME credit. There are no pre-requisites and there is no fee to participate in this activity or to receive CME credit. Statements of Credit are awarded upon successful completion of the post-test and evaluation form.

Media: Enduring Material
Release and Expiration Dates: June 17, 2016- June 16, 2017
Time to Complete: 105 minutes

Faculty & Disclosure / Conflict of Interest Policy

Before the activity, all faculty and anyone who is in a position to have control over the content of this activity and their spouse/life partner will disclose the existence of any financial interest and/or relationship(s) they might have with any commercial interest producing healthcare goods/services to be discussed during their presentation(s): honoraria, expenses, grants, consulting roles, speakers bureau membership, stock ownership, or other special relationships. Presenters will inform participants of any off-label discussions. All identified conflicts of interest are thoroughly vetted by Medical Learning Institute, Inc. for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

The associates of Medical Learning Institute, Inc., the accredited provider for this activity, and PVI, PeerView Institute for Medical Education do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this CME activity for any amount during the past 12 months.

Course Director and Moderator

Matt T. Rosenberg, MD
Medical Director
Mid-Michigan Health Centers
Jackson, Michigan

Matt T. Rosenberg, MD, has a financial interest/relationship or affiliation in the form of:
Consultant for Bayer; Medtronic; OPKO Health Inc.; and TOLMAR Pharmaceuticals, Inc.
Speakers Bureau participant with Astellas and OPKO Health Inc.

Matt T. Rosenberg, MD, does not intend to discuss any non-FDA-approved or investigational use of any products/devices.

Faculty

Theodore W. Johnson, II, MD, MPH
Paul W. Seavey Chair in Medicine
Emory University School of Medicine
Atlanta Site Director, Birmingham/Atlanta VA GRECC
Chief, Emory Division of General Medicine and Geriatrics
Chair, Emory Department of Family and Preventive Medicine
Atlanta, Georgia

Theodore W. Johnson, II, MD, MPH, has a financial interest/relationship or affiliation in the form of:
Consultant for Medtronic and Vantia Therapeutics.

Theodore W. Johnson, II, MD, MPH, does not intend to discuss any non-FDA-approved or investigational use of any products/devices.

Scott A. MacDiarmid, MD
Director
Alliance Urology Specialists Bladder Control and Pelvic Pain Center
Clinical Professor
Dept. of Urology
University of North Carolina
Chapel Hill, North Carolina

Scott A. MacDiarmid, MD, has a financial interest/relationship or affiliation in the form of:
Consultant for Allergan; Astellas; Cogentix Medical; and Medtronic.

Scott A. MacDiarmid, MD, does intend to discuss either non-FDA-approved or investigational use for the following products/devices: Combination therapy with antimuscarinics and mirabegron in the management of overactive bladder.

CME Reviewer

Matthew A. Goodman, MD
Attending Physician Internal Medicine
Abington Jefferson Health
Maple Glen, Pennsylvania

Matthew A. Goodman, MD, has no financial interests/relationships or affiliations in relation to this activity.

Medical Director

Aarati Ranganathan, PhD
PVI, PeerView Institute for Medical Education

Aarati Ranganathan, PhD, has no financial interests/relationships or affiliations in relation to this activity.

Disclaimer

The information provided at this CME activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient's medical condition. Recommendations for the use of particular therapeutic agents are based on the best available scientific evidence and current clinical guidelines. No bias towards or promotion for any agent discussed in this program should be inferred.

Providership, Credit & Support

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Medical Learning Institute, Inc. and PVI, PeerView Institute for Medical Education. The Medical Learning Institute, Inc. is accredited by the ACCME to provide continuing medical education for physicians.

The Medical Learning Institute, Inc. designates this enduring material for a maximum of 1.75 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Providership

This CME activity is jointly provided by Medical Learning Institute, Inc. and PVI, PeerView Institute for Medical Education.

Support

This activity is supported by an educational grant from Astellas.

Disclosure of Unlabeled Use

The faculty of this educational activity may include discussions of products or devices that are not currently labeled for use by the FDA. Faculty members have been advised to disclose to the audience any reference to an unlabeled or investigational use.

No endorsement of unapproved products or uses is made or implied by coverage of these products or uses in our reports. No responsibility is taken for errors or omissions in reports.

Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings.

The materials presented here are used with the permission of the authors and/or other sources. These materials do not necessarily reflect the views of PeerView Press or any of its partners, providers, and/or supporters.

Copyright © 2000-2016, PeerView Press - Medical Education Resource

Suggest a CME Activity

Please provide below the URL and description of an activity you would like to add to OpenCME. You are welcome to add activities as often as you like. To prevent spam or other abuse, activities are reviewed by our editorial team before appearing on OpenCME.

OpenCME for Publishers

Please use the form below if you would like to offer your website visitors high-quality CME content by adding the OpenCME Widget to one or more of your pages.

Send Email to a Colleague

To share this activity with one or more colleagues, enter their e-mail addresses below. To include a personal message, simply overwrite the suggested text below.

(So your recipient knows it's from you.)
Enter multiple recipients separated by a space.
Optionally, replace/modify in the box above the message that will be sent to your colleague(s) with a link to download this app.